Business

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing...

U2Fx.comU2Fx.com
Aug 4, 2026 - 14:00
 0  2
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing...
Read More

Tags:

Previous Article

Repeated bin rule breach lands company in court

Next Article

Reformation's IPO has made it a billion-dollar company

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

Tesla recalls some Cybertrucks because the light bar may fly off

Tesla recalls some Cybertrucks because the light bar ma...

U2Fx.com Oct 30, 2025  0  31

Springfield trash company accused of unfair business practices

Springfield trash company accused of unfair business pr...

U2Fx.com Jul 2, 2026  0  6

AB Foods Considers Separation of Its Primark, Food Businesses

AB Foods Considers Separation of Its Primark, Food Busi...

U2Fx.com Nov 4, 2025  0  20